Device typeBladder tumour-associated mutation IVD, probe: A defined piece of single-stranded nucleic acid which is used to identify specific complementary-sequence nucleic acid molecules in an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict one or multiple acquired mutations e.g., of chromosome 3, 7 and 17, associated with bladder cancer.
FDA categoryTest, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Device ID00884999002180
Catalog number02J27-095
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information